Anchor Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84K | Sell |
13
-23
| -64% | -$5.03K | ﹤0.01% | 933 |
|
|
2025
Q1 | $8.06K | Hold |
36
| – | – | ﹤0.01% | 823 |
|
|
2024
Q4 | $11.8K | Hold |
36
| – | – | ﹤0.01% | 772 |
|
|
2024
Q3 | $10.8K | Hold |
36
| – | – | ﹤0.01% | 770 |
|
|
2024
Q2 | $11.9K | Hold |
36
| – | – | ﹤0.01% | 719 |
|
|
2024
Q1 | $14.2K | Buy |
36
+23
| +177% | +$9.1K | ﹤0.01% | 722 |
|
|
2023
Q4 | $4.58K | Hold |
13
| – | – | ﹤0.01% | 824 |
|
|
2023
Q3 | $4.88K | Hold |
13
| – | – | ﹤0.01% | 833 |
|
|
2023
Q2 | $4.97K | Hold |
13
| – | – | ﹤0.01% | 827 |
|
|
2023
Q1 | $4.5K | Hold |
13
| – | – | ﹤0.01% | 844 |
|
|
2022
Q4 | $3.06K | Hold |
13
| – | – | ﹤0.01% | 849 |
|
|
2022
Q3 | $3.2K | Hold |
13
| – | – | ﹤0.01% | 852 |
|
|
2022
Q2 | $3.93K | Hold |
13
| – | – | ﹤0.01% | 841 |
|
|
2022
Q1 | $5.34K | Hold |
13
| – | – | ﹤0.01% | 832 |
|
|
2021
Q4 | $6.1K | Buy |
+13
| New | +$6.1K | ﹤0.01% | 850 |
|